Xvivo Perfusion: Positive results from the PrimECC study
The analysis of the clinical trial with PrimECC showed positive findings. PrimECC continued to show a good safety profile and reduced the side effects when used as a priming solution for heart-lung machines. Today's news will not result in any changes in our valuation of the company, but we see that further development is warranted.